Pfizer Settles Lipitor Battles With Ranbaxy
Under the settlement, Ranbaxy will be able to sell generic versions of Lipitor and Caduet starting Nov. 20, 2011. Caduet is a combination of Lipitor and a high blood pressure medication called Norvasc, another Pfizer product.
Lipitor is the world's most prescribed drug, with worldwide sales in 2007 of $12.7 billion. The largest market for Lipitor...
To view the full article, register now.